Targeting epigenetics: A novel promise for Alzheimer's disease treatment

D Jeremic, L Jiménez-Díaz, JD Navarro-López - Ageing Research Reviews, 2023 - Elsevier
So far, the search for a cure for Alzheimer Disease (AD) has been unsuccessful. The only
approved drugs attenuate some symptoms, but do not halt the progress of this disease …

Neuroepigenetics of ageing and neurodegeneration-associated dementia: an updated review

FA Mir, A Amanullah, BP Jain, Z Hyderi… - Ageing Research …, 2023 - Elsevier
Gene expression is tremendously altered in the brain during memory acquisition, recall, and
forgetfulness. However, non-genetic factors, including environmental elements, epigenetic …

Transgenerational Epigenetic DNA Methylation Editing and Human Disease

JD Tompkins - Biomolecules, 2023 - mdpi.com
During gestation, maternal (F0), embryonic (F1), and migrating primordial germ cell (F2)
genomes can be simultaneously exposed to environmental influences. Accumulating …

Neuroprotective factors affect the progression of Alzheimer's disease

Y Liu, J Tian - Biochemical and Biophysical Research …, 2023 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disease that occurs mostly in the elderly
and is characterized by chronic progressive cognitive dysfunction, which seriously threatens …

Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy

S Nohesara, HM Abdolmaleky, S Thiagalingam… - …, 2024 - Taylor & Francis
The origins of Alzheimer's disease (AD) and Parkinson's disease (PD) involve genetic
mutations, epigenetic changes, neurotoxin exposure and gut microbiota dysregulation. The …

Whole genome methylation sequencing in blood identifies extensive differential DNA methylation in late‐onset dementia due to Alzheimer's disease

C Breen, LA Papale, LR Clark… - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION DNA microarray‐based studies report differentially methylated positions
(DMPs) in blood between late‐onset dementia due to Alzheimer's disease (AD) and …

Stability of genomic imprinting and X-chromosome inactivation in the aging brain

S Mancino, J Seneviratne, A Mupo, F Krueger, D Oxley… - bioRxiv, 2023 - biorxiv.org
Epigenetic drift is a hallmark of aging that contributes to the irreversible decline in
organismal fitness ultimately leading to aging-related diseases. Epigenetic modifications …

Integrated analyses of 5mC, 5hmC methylation and gene expression reveal pathology-associated AKT3 gene and potential biomarkers for Alzheimer's disease

Y Shen, W Zhu, S Li, Z Zhang, J Zhang, M Li… - Journal of Psychiatric …, 2024 - Elsevier
Aims 5mC methylation and hydroxymethylation (5hmC) are associated with Alzheimer's
disease (AD). However, previous studies were limited by the absence of a 5hmC calculation …

Extended genome‐wide association study employing the African genome resources panel identifies novel susceptibility loci for Alzheimer's disease in individuals of …

NR Ray, BW Kunkle, K Hamilton‐Nelson… - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION Despite a two‐fold risk, individuals of African ancestry have been
underrepresented in Alzheimer's disease (AD) genomics efforts. METHODS Genome‐wide …

Tau protein modulates an epigenetic mechanism of cellular senescence in human SH-SY5Y neuroblastoma cells

C Magrin, M Bellafante, M Sola, E Piovesana… - Frontiers in Cell and …, 2023 - frontiersin.org
Introduction: Progressive Tau deposition in neurofibrillary tangles and neuropil threads is
the hallmark of tauopathies, a disorder group that includes Alzheimer's disease. Since Tau is …